Results 91 to 100 of about 2,542 (110)

Assessing the benefit of incorporating an anti-CD38 monoclonal antibody into second- or third-line systemic treatment for patients with relapsed/refractory multiple myeloma: results from the French real-world EMMY study. [PDF]

Haematologica
Chalopin T, Hulin C, Royer B, Bastie JN, Bobin A, Merzoug KB, Macro M, Karlin L, Jacquet C, Mohty M, Frenzel L, Sonntag C, Fontan J, Rigaudeau S, Roussel M, Sanhes L, Chaoui D, Vincent L, Orfeuvre H, Bouketouche M, Garlantezec R, Decaux O, Perrot A.   +22 more
europepmc   +1 more source

Commentary: Internal medicine at the crossroads of long COVID diagnosis and management. [PDF]

Front Med (Lausanne)
Spanoghe M, Molmans THJ, Antonacci T, Burel E, Herschke F, Schneider N, Oustric P, Thielemans P, Nicolas JB, Dauby N, Nicaise C, Van Weyenbergh J, Jamoulle M.   +12 more
europepmc   +1 more source

Élaboration des normes canadiennes de soins infirmiers en thérapie cellulaire. [PDF]

Can Oncol Nurs J
Page C, Bauder A, Cosencova L, Holmes LA, Joyce S, Kozlowski M, Longworth C, Maier S, McAfee J, McLean A, Pommier R, St Jean R, Vavra A, Richer J.   +13 more
europepmc   +1 more source

High-risk genomic consensus validation for patients with newly diagnosed multiple myeloma using next-generation sequencing. [PDF]

Blood
Schavgoulidze A, Perrot A, Leleu X, Cazaubiel T, Chretien ML, Feugier P, Belhadj K, Manier S, Roussel M, Brechignac S, Orsini-Piocelle F, Mohty M, Schiano de Collela JM, Macro M, Adiko D, Dib M, Fontan J, Luttiau-Motard C, Bouscary D, Pascal L, Roland V, Lifermann F, Bakala J, Montes L, Kennel C, Rey P, Richez V, Keddar F, Frenzel L, Calmettes C, Chaleteix C, Plantier I, Chalayer E, Schmitt A, Roul C, Demarquette H, Cerutti C, Pavageau L, Derrier L, Avet-Loiseau H, Corre J.   +40 more
europepmc   +1 more source

Évaluation par les parents et les infirmières pivots de l’outil de dépistage de la détresse chez les proches aidants de patients en oncologie pédiatrique : étude de faisabilité exploratoire. [PDF]

Can Oncol Nurs J
Bernier P, Desjardins L, Charette MC, Latour MP, Ho KL.   +4 more
europepmc   +1 more source

Does stringent cytoreduction improve survival in advanced proliferative chronic myelomonocytic leukemia? [PDF]

Leukemia
Selimoglu-Buet D, Chevret S, Santini V, Thépot S, Morabito M, Adès L, Laplane L, Giagounidis A, Droin N, Lübbert M, Sapena R, Nimubona S, Torregrosa-Diaz JM, Germing U, Pelizzari AM, Park S, Jaekel N, Metzgeroth G, Onida F, Paul F, Patriarca A, Stamatoullas A, Götze K, Chermat F, Platzbecker U, Fenaux P, Solary E, Itzykson R.   +27 more
europepmc   +1 more source

Thrombopénie récurrente avec agrégation plaquettaire chez une femme enceinte. [PDF]

CMAJ
Khalife R, Mahdi T, Tinmouth A.
europepmc   +1 more source

Inflammatory disorders in IDH-mutated myeloid neoplasms: Characteristics and response to IDH inhibitors. [PDF]

Hemasphere
Stammler R, Chen P, Debeaupuis O, Zhao LP, Ruyer-Thompson M, Zakine E, Rossignol J, Goldwirt L, Comont T, Heiblig M, Adès L, Sebert M, Allain JS, Campagne J, Couturier MA, Cumin M, Dalmas MC, Denis G, Devloo C, De Voeght A, Drevon L, Duffau P, Georgin-Lavialle S, Gobert D, Kosmider O, Rieux-Laucat F, Abisror N, Lazaro E, Lopez JG, Maria A, Mauhin W, Merindol J, Merlot C, Mirault T, Pascal L, Perrin F, Raffoux E, Rahme R, Roos-Weil D, Terrier B, Thoreau B, Fain O, Fenaux P, Hirsch P, Jachiet V, Hadjadj J, Mékinian A, MINHEMON.   +47 more
europepmc   +1 more source

Constructing an External Control Arm Using the French REALYSA Cohort to Replicate Outcomes of a Randomized Trial Arm in Advanced Hodgkin Lymphoma. [PDF]

Clin Pharmacol Ther
Febvey-Combes O, Rossi C, Kassai B, Murairi Mirimo T, Chartier L, Cherblanc F, Cugnod E, Ghesquières H, Belot A.   +8 more
europepmc   +1 more source

Stage I placental site trophoblastic tumor with complete response after pembrolizumab. [PDF]

Gynecol Oncol Rep
Descargues P, Eiriksson LR, Rousset P, Msika A, You B, Trecourt A, Massardier J, Hajri T, Borghese B, Golfier F, Bolze PA, Alexandre J.   +11 more
europepmc   +1 more source